Details of the Drug Combinations

General Information of This Drug (ID: DMIXMYK)

Drug Name
Arfolitixorin   DMIXMYK
Synonyms
(6R)-5,10-Methylenetetrahydrofolate; Modufolin; UNII-Z8R4A37V9Q; 31690-11-6; Methylenetetrahydrofolic acid, L-(+)-; (6R)-5,10-methylenetetrahydrofolic acid; CHEBI:1989; Z8R4A37V9Q; L-(+)-methylenetetrahydrofolic acid; 31690-11-6 (free); 5,10-methylene-THF; 5,10-methylenetetrahydrofolate; 3432-99-3; (4-((R)-3-amino-1-oxo-1,2,5,6,6a,7-hexahydroimidazo[1,5-f]pteridin-8(9H)-yl)benzoyl)-L-glutamic acid; N-({4-[(6ar)-3-Amino-1-Oxo-1,2,5,6,6a,7-Hexahydroimidazo[1,5-F]pteridin-8(9h)-Yl]phenyl}carbonyl)-L-Glutamic Acid; N-{4-[(6aR)-3-amino-1-oxo-1,2,5,6,6a,7-hexahydroimidazo[1,5-f]pteridin-8(9H)-yl]benzoyl}-L-glutamic acid; Arfolitixorin [USAN]; 6R-MTHF; Arfolitixorin (USAN/INN); SCHEMBL186747; CHEMBL1234270; DTXSID60185584; ISO-901; BCP09003; ZINC4228243; (6R)-5,10-MTHF; WHO 10689; DB12676; 5,10-methylene-(6r)-tetrahydrofolic acid; 5,10-methylene,5,6,7,8-tetrahydrofolate; D11447; Q26995704; (6r,s)-5,10-methylene-5,6,7,8-tetrahydrofolic acid; [6R]-5,10-methylenetetrahydrofolate ([6R]-5,10- MTHF); UNII-0SXY5ET48B component QYNUQALWYRSVHF-OLZOCXBDSA-N; (S)-2-(4-((R)-3-Amino-1-oxo-5,6,6a,7-tetrahydroimidazo[1,5-f]pteridin-8(1H,4H,9H)-yl)benzamido)pentanedioic acid; N-({4-[(6aR)-3-amino-1-oxo-1,4,5,6,6a,7-hexahydroimidazo[1,5-f]pteridin-8(9H)-yl]phenyl}carbonyl)-L-glutamic acid
Indication
Disease Entry ICD 11 Status REF
Colorectal cancer 2B91.Z Phase 3 [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

595 Investigative Drug Combination(s) Consisting of This drug
Normalized Drug Combination Synergy Score
Synergy scores were normalized using Min-Max Scaling to facilitate visual comparisons.
DrugCom Name DrugCom ID Component Drug Indication REF
ABIRATERONE + Arfolitixorin DC1S32L ABIRATERONE Renal cell carcinoma (Cell Line: SN12C) [2]
ABIRATERONE + Arfolitixorin DCCKRNS ABIRATERONE Carcinoma (Cell Line: RXF 393) [3]
ABIRATERONE + Arfolitixorin DCYA4W8 ABIRATERONE Adenocarcinoma (Cell Line: DU-145) [4]
ABIRATERONE + Arfolitixorin DCI8K6N ABIRATERONE Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [4]
Acamprosate + Arfolitixorin DCKG57X Acamprosate Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Acetazolamide + Arfolitixorin DCT004B Acetazolamide Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Acetohexamide + Arfolitixorin DCX4B8R Acetohexamide Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Acetohydroxamic Acid + Arfolitixorin DCSYP9O Acetohydroxamic Acid Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Amantadine + Arfolitixorin DCVENAY Amantadine Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Amiloride + Arfolitixorin DCS59GQ Amiloride Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Aminosalicylic acid + Arfolitixorin DCC382U Aminosalicylic acid Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Amonafide + Arfolitixorin DC42ODQ Amonafide Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
Amonafide + Arfolitixorin DCW9VC2 Amonafide Anaplastic large cell lymphoma (Cell Line: SR) [2]
Amonafide + Arfolitixorin DCBQIM9 Amonafide Glioma (Cell Line: SF-268) [2]
Amonafide + Arfolitixorin DCH6E61 Amonafide Large cell lung carcinoma (Cell Line: NCI-H460) [2]
Amonafide + Arfolitixorin DCE28IS Amonafide Malignant melanoma (Cell Line: LOX IMVI) [2]
Amonafide + Arfolitixorin DCGUCD8 Amonafide Carcinoma (Cell Line: RXF 393) [3]
Amonafide + Arfolitixorin DC6KQ78 Amonafide Colon adenocarcinoma (Cell Line: COLO 205) [3]
Amonafide + Arfolitixorin DCZLLFO Amonafide Colon carcinoma (Cell Line: KM12) [3]
Anastrozole + Arfolitixorin DCA6DL5 Anastrozole Astrocytoma (Cell Line: SNB-19) [2]
Anastrozole + Arfolitixorin DCTA4V4 Anastrozole Clear cell renal cell carcinoma (Cell Line: TK-10) [2]
Anastrozole + Arfolitixorin DCY7U3V Anastrozole Clear cell renal cell carcinoma (Cell Line: CAKI-1) [2]
Anastrozole + Arfolitixorin DCSEYWU Anastrozole Glioma (Cell Line: SF-268) [2]
Anastrozole + Arfolitixorin DC6KCT3 Anastrozole Lung adenocarcinoma (Cell Line: NCI-H522) [2]
Anastrozole + Arfolitixorin DCDVTZT Anastrozole Malignant melanoma (Cell Line: LOX IMVI) [2]
Anastrozole + Arfolitixorin DCKV4QU Anastrozole Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [2]
Anastrozole + Arfolitixorin DC2YA88 Anastrozole Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [2]
Anastrozole + Arfolitixorin DCGJN2J Anastrozole Papillary renal cell carcinoma (Cell Line: ACHN) [2]
Anastrozole + Arfolitixorin DCOYMYI Anastrozole Prostate carcinoma (Cell Line: PC-3) [2]
Anastrozole + Arfolitixorin DC4J5QL Anastrozole Breast adenocarcinoma (Cell Line: MDA-MB-468) [3]
Anastrozole + Arfolitixorin DCZ9UE2 Anastrozole Carcinoma (Cell Line: RXF 393) [3]
Anastrozole + Arfolitixorin DC0E1I4 Anastrozole Colon adenocarcinoma (Cell Line: COLO 205) [3]
Anastrozole + Arfolitixorin DCWRPWF Anastrozole Colon carcinoma (Cell Line: KM12) [3]
Arfolitixorin + Meclofenamic acid DCHZCKO Meclofenamic acid Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + Mebutamate DCM0WFE Mebutamate Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + Baclofen DC8UVBE Baclofen Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + Bepridil DCKYWT5 Bepridil Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + Fulvestrant DCSFLOT Fulvestrant Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Arfolitixorin + Clindamycin DC8MJYR Clindamycin Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + Diethylcarbamazine DC94ZD1 Diethylcarbamazine Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + Lumefantrine DC0TZN8 Lumefantrine Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + Triamterene DCYBTC5 Triamterene Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + Dactinomycin DCU70KY Dactinomycin Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Arfolitixorin + Dactinomycin DCQH0KC Dactinomycin Anaplastic large cell lymphoma (Cell Line: SR) [2]
Arfolitixorin + Dactinomycin DCH007H Dactinomycin Chronic myelogenous leukemia (Cell Line: K-562) [2]
Arfolitixorin + Dactinomycin DCK87Q7 Dactinomycin Glioma (Cell Line: SF-268) [2]
Arfolitixorin + Dactinomycin DCD78ZN Dactinomycin Glioma (Cell Line: SF-539) [2]
Arfolitixorin + Dactinomycin DCW681V Dactinomycin Papillary renal cell carcinoma (Cell Line: ACHN) [2]
Arfolitixorin + Dactinomycin DCJOHFU Dactinomycin Plasma cell myeloma (Cell Line: RPMI-8226) [2]
Arfolitixorin + Lapatinib DCX3AP6 Lapatinib Astrocytoma (Cell Line: SNB-19) [2]
Arfolitixorin + Lapatinib DC49AOR Lapatinib Glioma (Cell Line: SF-295) [2]
Arfolitixorin + Terazosin DCQPRM1 Terazosin Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + Tindamax DC1L1HF Tindamax Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + PMID28460551-Compound-2 DCR40PI PMID28460551-Compound-2 Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Arfolitixorin + PMID28460551-Compound-2 DC4BDNY PMID28460551-Compound-2 Anaplastic large cell lymphoma (Cell Line: SR) [2]
Arfolitixorin + PMID28460551-Compound-2 DCPHICQ PMID28460551-Compound-2 Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + PMID28460551-Compound-2 DCVUV71 PMID28460551-Compound-2 Renal cell carcinoma (Cell Line: SN12C) [2]
Arfolitixorin + Crizotinib DCS2V86 Crizotinib Glioma (Cell Line: SF-295) [2]
Arfolitixorin + LIAROZOLE DC62O44 LIAROZOLE Glioma (Cell Line: SF-268) [2]
Arfolitixorin + Tacrine DC2WA76 Tacrine Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + Isoniazid DC5DTTR Isoniazid Clear cell renal cell carcinoma (Cell Line: CAKI-1) [2]
Arfolitixorin + Mephenytoin DCRX3Q9 Mephenytoin Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + Vemurafenib DCULCVT Vemurafenib Glioma (Cell Line: SF-295) [2]
Arfolitixorin + Ezetimibe DCCR9R8 Ezetimibe Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + Plicamycin DCNUH3W Plicamycin Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
Arfolitixorin + Plicamycin DCHQNJA Plicamycin Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Arfolitixorin + Plicamycin DCAX9WE Plicamycin Astrocytoma (Cell Line: U251) [2]
Arfolitixorin + Plicamycin DCJIOHM Plicamycin Chronic myelogenous leukemia (Cell Line: K-562) [2]
Arfolitixorin + Plicamycin DCXGX2G Plicamycin Clear cell renal cell carcinoma (Cell Line: A498) [2]
Arfolitixorin + Plicamycin DCE48U2 Plicamycin Clear cell renal cell carcinoma (Cell Line: CAKI-1) [2]
Arfolitixorin + Plicamycin DCU3RMA Plicamycin Glioblastoma (Cell Line: SNB-75) [2]
Arfolitixorin + Plicamycin DC0BYLO Plicamycin Glioma (Cell Line: SF-268) [2]
Arfolitixorin + Plicamycin DCBTP00 Plicamycin Glioma (Cell Line: SF-539) [2]
Arfolitixorin + Plicamycin DCPNN7J Plicamycin Plasma cell myeloma (Cell Line: RPMI-8226) [2]
Arfolitixorin + Testosterone DC0SXWN Testosterone Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + Nilotinib DC7K86Y Nilotinib Anaplastic large cell lymphoma (Cell Line: SR) [2]
Arfolitixorin + Dexmedetomidine DCQ37CQ Dexmedetomidine Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + Tranexamic acid DCCH5UE Tranexamic acid Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + Pepstatin DC38HUR Pepstatin Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + 10-hydroxycamptothecin DC75YUX 10-hydroxycamptothecin Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
Arfolitixorin + 10-hydroxycamptothecin DC7LKBI 10-hydroxycamptothecin Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + 10-hydroxycamptothecin DCSSQ3V 10-hydroxycamptothecin Glioma (Cell Line: SF-295) [2]
Arfolitixorin + Topetecan DCCPRC4 Topetecan Anaplastic large cell lymphoma (Cell Line: SR) [2]
Arfolitixorin + Topetecan DC5N9CK Topetecan Papillary renal cell carcinoma (Cell Line: ACHN) [2]
Arfolitixorin + Pralatrexate DCTLVAJ Pralatrexate Astrocytoma (Cell Line: SNB-19) [2]
Arfolitixorin + IT-141 DCSORQM IT-141 Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + Pamidronate DCW425L Pamidronate Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + Palonosetron DCB687U Palonosetron Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + BHV-0223 DCGB4W8 BHV-0223 Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + Efavirenz DCEAQNF Efavirenz Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + Testosterone cypionate DCHWH9R Testosterone cypionate Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + Guanfacine DCWZ0A8 Guanfacine Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + SCH 727965 DCRXCTX SCH 727965 Anaplastic large cell lymphoma (Cell Line: SR) [2]
Arfolitixorin + SCH 727965 DCLQPU6 SCH 727965 Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + SCH 727965 DC42NR2 SCH 727965 Glioma (Cell Line: SF-295) [2]
Arfolitixorin + Flavonoid derivative 1 DC8LOFX Flavonoid derivative 1 Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + Itraconazole DCNBTUB Itraconazole Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + Ifosfamide DCYTVLV Ifosfamide Plasma cell myeloma (Cell Line: RPMI-8226) [2]
Arfolitixorin + Ursodeoxycholic acid DCZXNSN Ursodeoxycholic acid Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + Doxapram DCLGL5D Doxapram Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + K-134 DCMGRSW K-134 Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + Memantine DCGAN6Z Memantine Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + Docetaxel DCAWOQO Docetaxel Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + Raloxifene DCQGL2D Raloxifene Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
Arfolitixorin + Raloxifene DCHLXKK Raloxifene Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Arfolitixorin + Raloxifene DCIS3Q7 Raloxifene Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [2]
Arfolitixorin + Raloxifene DCMN3N2 Raloxifene Glioma (Cell Line: SF-539) [2]
Arfolitixorin + ETHISTERONE DCGKST6 ETHISTERONE Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + LY03004 DCFH555 LY03004 Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + Marizomib DCABOGD Marizomib Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [2]
Arfolitixorin + Phensuximide DCTWV3V Phensuximide Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + Bendamustine hydrochloride DCLRDGH Bendamustine hydrochloride Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Arfolitixorin + VR-776 DC8D5ED VR-776 Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + WAY-100635 DC5591P WAY-100635 Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + Ciprofibrate DCS4DW4 Ciprofibrate Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + Mecamylamine DCD8PD8 Mecamylamine Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + Sirolimus DCSSKQE Sirolimus Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Arfolitixorin + PHA-739358 DC71KSZ PHA-739358 Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + Mitomycin DCYODNY Mitomycin Astrocytoma (Cell Line: U251) [2]
Arfolitixorin + Mitomycin DCL4UT1 Mitomycin Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [2]
Arfolitixorin + Mitomycin DCTOIPO Mitomycin Clear cell renal cell carcinoma (Cell Line: CAKI-1) [2]
Arfolitixorin + Mitomycin DCSSYX2 Mitomycin Glioma (Cell Line: SF-268) [2]
Arfolitixorin + Mitomycin DCRVOMS Mitomycin Plasma cell myeloma (Cell Line: RPMI-8226) [2]
Arfolitixorin + Clopidogrel DCMX0MB Clopidogrel Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + Diphenidol DCAJZEO Diphenidol Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + Tolazoline DCRP1S1 Tolazoline Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + Procarbazine DCAAKQB Procarbazine Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + Vincristine DCTONSL Vincristine Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Arfolitixorin + Vincristine DC19SOM Vincristine Anaplastic large cell lymphoma (Cell Line: SR) [2]
Arfolitixorin + Vincristine DCEL0Y8 Vincristine Clear cell renal cell carcinoma (Cell Line: 786-0) [2]
Arfolitixorin + PFK-158 DCHAKYC PFK-158 Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + Sulfapyridine DCN31UQ Sulfapyridine Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + Triflupromazine DCT3Z69 Triflupromazine Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + Lubiprostone DCPVK5R Lubiprostone Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + Etonogestrel DCXFD33 Etonogestrel Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + Trifluoperazine DCGKAS5 Trifluoperazine Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + Diazoxide DCEABHT Diazoxide Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + JNK-IN-8 DC3TQZ2 JNK-IN-8 Astrocytoma (Cell Line: SNB-19) [2]
Arfolitixorin + Idarubicin DC4372C Idarubicin Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + Methocarbamol DCSR56E Methocarbamol Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + Imatinib DCWVIVX Imatinib Astrocytoma (Cell Line: SNB-19) [2]
Arfolitixorin + Imatinib DCS9PQU Imatinib Glioma (Cell Line: SF-295) [2]
Arfolitixorin + Probenecid DCU21JE Probenecid Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + Darunavir DC6B175 Darunavir Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + Bleomycin DCIIVWO Bleomycin Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
Arfolitixorin + Bleomycin DCOZBS4 Bleomycin Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Arfolitixorin + Bleomycin DC3S00T Bleomycin Anaplastic large cell lymphoma (Cell Line: SR) [2]
Arfolitixorin + Bleomycin DC0RDVT Bleomycin Chronic myelogenous leukemia (Cell Line: K-562) [2]
Arfolitixorin + Bleomycin DCXMYSW Bleomycin Plasma cell myeloma (Cell Line: RPMI-8226) [2]
Arfolitixorin + Pramipexole DCQ3E1X Pramipexole Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + Bortezomib DCOUXMY Bortezomib Glioma (Cell Line: SF-295) [2]
Arfolitixorin + Tropisetron DCW7REH Tropisetron Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + Mebendazole DCOBP9P Mebendazole Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + Mesalazine DCK8IY5 Mesalazine Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + Moricizine DCAYIF7 Moricizine Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + Valrubicin DCJTB36 Valrubicin Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Arfolitixorin + Dopamine DCJ3336 Dopamine Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + Trimethobenzamide DCTVDC3 Trimethobenzamide Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + Enalaprilat DC130EH Enalaprilat Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + Ethambutol DC4J6U6 Ethambutol Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + Chlorambucil DCVDCRG Chlorambucil Anaplastic large cell lymphoma (Cell Line: SR) [2]
Arfolitixorin + Chlorambucil DCEKV6C Chlorambucil Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + Chlorambucil DCL69VX Chlorambucil Glioma (Cell Line: SF-295) [2]
Arfolitixorin + Sorafenib DC0OG8W Sorafenib Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Arfolitixorin + Sorafenib DCDT43Y Sorafenib Anaplastic large cell lymphoma (Cell Line: SR) [2]
Arfolitixorin + Sorafenib DCUQRT9 Sorafenib Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + ER819762 DCVZP2M ER819762 Anaplastic large cell lymphoma (Cell Line: SR) [2]
Arfolitixorin + Asenapine DC7DUMN Asenapine Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + Quinine DC8U28S Quinine Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + Azacitidine DCTZYAJ Azacitidine Plasma cell myeloma (Cell Line: RPMI-8226) [2]
Arfolitixorin + Pomalidomide DCK3IJ0 Pomalidomide Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + Pomalidomide DCZNPY6 Pomalidomide Clear cell renal cell carcinoma (Cell Line: CAKI-1) [2]
Arfolitixorin + Pomalidomide DCV1398 Pomalidomide Glioma (Cell Line: SF-295) [2]
Arfolitixorin + Pomalidomide DCD8V0J Pomalidomide Renal cell carcinoma (Cell Line: SN12C) [2]
Arfolitixorin + Maraviroc DCHOR2M Maraviroc Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + Oxandrolone DCUQLAH Oxandrolone Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + Mefloquine DCXMA1O Mefloquine Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + Zileuton DC42SA1 Zileuton Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + Fludarabine DCIJTTX Fludarabine Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Arfolitixorin + Nabilone DC0CFCH Nabilone Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + Testolactone DCC48AP Testolactone Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + Sumatriptan DCC1IIS Sumatriptan Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + Rufinamide DCJIHTV Rufinamide Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + FORMESTANE DCJ4P5U FORMESTANE Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Arfolitixorin + Vorinostat DCPHE52 Vorinostat Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + Aminolevulinic Acid Hydrochloride DC4XK0M Aminolevulinic Acid Hydrochloride Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Arfolitixorin + Aminolevulinic Acid Hydrochloride DCD3VLZ Aminolevulinic Acid Hydrochloride Anaplastic large cell lymphoma (Cell Line: SR) [2]
Arfolitixorin + Estramustine DCBLXEK Estramustine Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Arfolitixorin + Cerivastatin DCOBR4C Cerivastatin Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + Hydroxychloroquine DCACQOC Hydroxychloroquine Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + Atovaquone DCB4046 Atovaquone Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + Enoxacin DC3EBFZ Enoxacin Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + Raltegravir DCYXKHL Raltegravir Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + Albendazole DCSG7KY Albendazole Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + AS-1949490 DCRE89H AS-1949490 Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + Dasatinib DCXLB21 Dasatinib Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
Arfolitixorin + Dasatinib DCWCPXH Dasatinib Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Arfolitixorin + Dasatinib DCXJF1L Dasatinib Anaplastic large cell lymphoma (Cell Line: SR) [2]
Arfolitixorin + Dasatinib DCMYLZU Dasatinib Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [2]
Arfolitixorin + Dasatinib DCYO92B Dasatinib Chronic myelogenous leukemia (Cell Line: K-562) [2]
Arfolitixorin + Dasatinib DCMHGZV Dasatinib Clear cell renal cell carcinoma (Cell Line: 786-0) [2]
Arfolitixorin + Dasatinib DCGWUAV Dasatinib Glioblastoma (Cell Line: SNB-75) [2]
Arfolitixorin + Dasatinib DCDMIZ3 Dasatinib Glioma (Cell Line: SF-539) [2]
Arfolitixorin + Tacrolimus DC4BGBN Tacrolimus Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + Cilostazol DCMYY9I Cilostazol Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + Dactinomycin DCFR36Z Dactinomycin Carcinoma (Cell Line: RXF 393) [3]
Arfolitixorin + Dactinomycin DC70EMT Dactinomycin Colon adenocarcinoma (Cell Line: COLO 205) [3]
Arfolitixorin + Dactinomycin DCD8YBF Dactinomycin Invasive ductal carcinoma (Cell Line: BT-549) [3]
Arfolitixorin + Lapatinib DCB3610 Lapatinib Carcinoma (Cell Line: MCF7) [3]
Arfolitixorin + PMID28460551-Compound-2 DC1YFUY PMID28460551-Compound-2 Carcinoma (Cell Line: RXF 393) [3]
Arfolitixorin + PMID28460551-Compound-2 DC9KZH2 PMID28460551-Compound-2 Colon carcinoma (Cell Line: KM12) [3]
Arfolitixorin + Methotrexate DC4OCJ0 Methotrexate Invasive ductal carcinoma (Cell Line: T-47D) [3]
Arfolitixorin + Isoniazid DCGIO1W Isoniazid Colon carcinoma (Cell Line: KM12) [3]
Arfolitixorin + Plicamycin DCLVOLC Plicamycin Breast adenocarcinoma (Cell Line: MDA-MB-468) [3]
Arfolitixorin + Plicamycin DCLR5YE Plicamycin Carcinoma (Cell Line: RXF 393) [3]
Arfolitixorin + Plicamycin DC114D2 Plicamycin Colon carcinoma (Cell Line: KM12) [3]
Arfolitixorin + Plicamycin DC9HH1T Plicamycin Invasive ductal carcinoma (Cell Line: BT-549) [3]
Arfolitixorin + Plicamycin DCQ0CNF Plicamycin Invasive ductal carcinoma (Cell Line: HS 578T) [3]
Arfolitixorin + Pralatrexate DCKKQHE Pralatrexate Carcinoma (Cell Line: MCF7) [3]
Arfolitixorin + Mitomycin DCCHWZ7 Mitomycin Carcinoma (Cell Line: MCF7) [3]
Arfolitixorin + Mitomycin DCBW0FH Mitomycin Invasive ductal carcinoma (Cell Line: HS 578T) [3]
Arfolitixorin + Mitomycin DCS5ZJH Mitomycin Invasive ductal carcinoma (Cell Line: BT-549) [3]
Arfolitixorin + Imatinib DCIQDHL Imatinib Carcinoma (Cell Line: MCF7) [3]
Arfolitixorin + Romidepsin DC3680L Romidepsin Invasive ductal carcinoma (Cell Line: BT-549) [3]
Arfolitixorin + Pomalidomide DC9E4GC Pomalidomide Colon carcinoma (Cell Line: KM12) [3]
Arfolitixorin + Mepacrine DC8RCNR Mepacrine Colon carcinoma (Cell Line: KM12) [3]
Arfolitixorin + Aminolevulinic Acid Hydrochloride DCN8QZU Aminolevulinic Acid Hydrochloride Invasive ductal carcinoma (Cell Line: BT-549) [3]
Arfolitixorin + Dasatinib DCE1C68 Dasatinib Breast adenocarcinoma (Cell Line: MDA-MB-468) [3]
Arfolitixorin + Dasatinib DCXEF8U Dasatinib Carcinoma (Cell Line: MCF7) [3]
Arfolitixorin + Ruxolitinib DCIW70F Ruxolitinib Hodgkin lymphoma (Cell Line: L-1236) [4]
Arfolitixorin + Ixabepilone DC9KF45 Ixabepilone Adenocarcinoma (Cell Line: HCT-15) [4]
Arfolitixorin + Dactinomycin DC4P0SR Dactinomycin Adenocarcinoma (Cell Line: A549) [4]
Arfolitixorin + Dactinomycin DCGAASF Dactinomycin Adenocarcinoma (Cell Line: HT29) [4]
Arfolitixorin + Dactinomycin DCS5T4A Dactinomycin Adenocarcinoma (Cell Line: HCT116) [4]
Arfolitixorin + Dactinomycin DCPKEBE Dactinomycin Adenocarcinoma (Cell Line: SW-620) [4]
Arfolitixorin + Dactinomycin DCGYUN5 Dactinomycin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [4]
Arfolitixorin + Dactinomycin DCX5Q8H Dactinomycin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [4]
Arfolitixorin + Dactinomycin DC57SHU Dactinomycin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [4]
Arfolitixorin + Dactinomycin DC7A851 Dactinomycin Large cell lung carcinoma (Cell Line: NCI-H460) [4]
Arfolitixorin + Dactinomycin DC22WTU Dactinomycin Lung adenocarcinoma (Cell Line: HOP-62) [4]
Arfolitixorin + Dactinomycin DC1B93N Dactinomycin Lung adenocarcinoma (Cell Line: NCI-H522) [4]
Arfolitixorin + Dactinomycin DCBP5DV Dactinomycin Malignant melanoma (Cell Line: LOX IMVI) [4]
Arfolitixorin + Dactinomycin DC0O6GF Dactinomycin Melanoma (Cell Line: MALME-3M) [4]
Arfolitixorin + Dactinomycin DCL9XZK Dactinomycin Melanoma (Cell Line: SK-MEL-2) [4]
Arfolitixorin + Dactinomycin DCRURO6 Dactinomycin Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [4]
Arfolitixorin + Dactinomycin DCEABY8 Dactinomycin Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [4]
Arfolitixorin + DFN-15 DCP04RL DFN-15 Adenocarcinoma (Cell Line: HCT116) [4]
Arfolitixorin + Lapatinib DCSFGNA Lapatinib Adenocarcinoma (Cell Line: HCT116) [4]
Arfolitixorin + PMID28460551-Compound-2 DCZZO7K PMID28460551-Compound-2 Lung adenocarcinoma (Cell Line: HOP-62) [4]
Arfolitixorin + PMID28460551-Compound-2 DCURU0A PMID28460551-Compound-2 Lung adenocarcinoma (Cell Line: MDA-MB-231) [4]
Arfolitixorin + PMID28460551-Compound-2 DCJJDFZ PMID28460551-Compound-2 Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [4]
Arfolitixorin + Crizotinib DCVT61R Crizotinib Adenocarcinoma (Cell Line: HCT-15) [4]
Arfolitixorin + Crizotinib DCXRZZ6 Crizotinib Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [4]
Arfolitixorin + LIAROZOLE DCOEAZ9 LIAROZOLE Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [4]
Arfolitixorin + Arsenic trioxide DCO5NPC Arsenic trioxide Adenocarcinoma (Cell Line: HT29) [4]
Arfolitixorin + Vemurafenib DC02Y2S Vemurafenib Cutaneous melanoma (Cell Line: SK-MEL-5) [4]
Arfolitixorin + Vemurafenib DCLKCPE Vemurafenib Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [4]
Arfolitixorin + Plicamycin DC9CFYG Plicamycin Adenocarcinoma (Cell Line: OVCAR3) [4]
Arfolitixorin + Plicamycin DCCUG75 Plicamycin Adenocarcinoma (Cell Line: A549) [4]
Arfolitixorin + Plicamycin DCGN1ZC Plicamycin Adenocarcinoma (Cell Line: HCT116) [4]
Arfolitixorin + Plicamycin DCPVDE6 Plicamycin Adenocarcinoma (Cell Line: HCC-2998) [4]
Arfolitixorin + Plicamycin DCW0WOI Plicamycin Adenocarcinoma (Cell Line: HT29) [4]
Arfolitixorin + Plicamycin DCVIR4L Plicamycin Amelanotic melanoma (Cell Line: MDA-MB-435) [4]
Arfolitixorin + Plicamycin DCD67ZE Plicamycin Cutaneous melanoma (Cell Line: SK-MEL-28) [4]
Arfolitixorin + Plicamycin DC2CMWL Plicamycin Cutaneous melanoma (Cell Line: SK-MEL-5) [4]
Arfolitixorin + Plicamycin DCXY2YC Plicamycin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [4]
Arfolitixorin + Plicamycin DCVHNT7 Plicamycin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [4]
Arfolitixorin + Plicamycin DCKVOC5 Plicamycin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [4]
Arfolitixorin + Plicamycin DCO9KER Plicamycin Large cell lung carcinoma (Cell Line: NCI-H460) [4]
Arfolitixorin + Plicamycin DCZ136F Plicamycin Lung adenocarcinoma (Cell Line: HOP-62) [4]
Arfolitixorin + Plicamycin DCJOF1H Plicamycin Lung adenocarcinoma (Cell Line: EKVX) [4]
Arfolitixorin + Plicamycin DCOMOI5 Plicamycin Lung adenocarcinoma (Cell Line: MDA-MB-231) [4]
Arfolitixorin + Plicamycin DC5FKCX Plicamycin Lung adenocarcinoma (Cell Line: NCI-H522) [4]
Arfolitixorin + Plicamycin DC1WPAR Plicamycin Malignant melanoma (Cell Line: LOX IMVI) [4]
Arfolitixorin + Plicamycin DC9EYB0 Plicamycin Malignant melanoma (Cell Line: UACC62) [4]
Arfolitixorin + Plicamycin DCSEYSD Plicamycin Melanoma (Cell Line: MALME-3M) [4]
Arfolitixorin + Plicamycin DC8GC5Q Plicamycin Melanoma (Cell Line: UACC-257) [4]
Arfolitixorin + Plicamycin DC893YD Plicamycin Melanoma (Cell Line: SK-MEL-2) [4]
Arfolitixorin + Plicamycin DCC5SVQ Plicamycin Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [4]
Arfolitixorin + Plicamycin DCJ5WHD Plicamycin Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [4]
Arfolitixorin + Plicamycin DCN8VSD Plicamycin Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [4]
Arfolitixorin + Plicamycin DCUAZVC Plicamycin Prostate carcinoma (Cell Line: PC-3) [4]
Arfolitixorin + Nilotinib DCS6CSH Nilotinib Adenocarcinoma (Cell Line: A549) [4]
Arfolitixorin + Nilotinib DCP7GPH Nilotinib Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [4]
Arfolitixorin + Terameprocol DCGX3AR Terameprocol Adenocarcinoma (Cell Line: HT29) [4]
Arfolitixorin + SCH 727965 DCZ6SRE SCH 727965 Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [4]
Arfolitixorin + Ifosfamide DCQDZYY Ifosfamide Adenocarcinoma (Cell Line: HCT116) [4]
Arfolitixorin + Raloxifene DCHIIDS Raloxifene High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [4]
Arfolitixorin + Bendamustine hydrochloride DC3NP2P Bendamustine hydrochloride Adenocarcinoma (Cell Line: A549) [4]
Arfolitixorin + Bendamustine hydrochloride DCAI1LB Bendamustine hydrochloride Adenocarcinoma (Cell Line: HCT116) [4]
Arfolitixorin + Bendamustine hydrochloride DCUGH33 Bendamustine hydrochloride Lung adenocarcinoma (Cell Line: NCI-H522) [4]
Arfolitixorin + Bendamustine hydrochloride DCJWKVZ Bendamustine hydrochloride Melanoma (Cell Line: MALME-3M) [4]
Arfolitixorin + Bendamustine hydrochloride DCZ8CMJ Bendamustine hydrochloride Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [4]
Arfolitixorin + Letrozole DC73MHN Letrozole Adenocarcinoma (Cell Line: HCT116) [4]
Arfolitixorin + Mitomycin DC9KAIA Mitomycin Adenocarcinoma (Cell Line: SW-620) [4]
Arfolitixorin + Mitomycin DCOEOYA Mitomycin Adenocarcinoma (Cell Line: HT29) [4]
Arfolitixorin + Mitomycin DCHF99G Mitomycin Adenocarcinoma (Cell Line: HCT116) [4]
Arfolitixorin + SY-1425 DCFHK26 SY-1425 Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [4]
Arfolitixorin + Altretamine DCOGLR8 Altretamine Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [4]
Arfolitixorin + Altretamine DC5FXUA Altretamine Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [4]
Arfolitixorin + TEM DCRJT9G TEM Adenocarcinoma (Cell Line: HCT116) [4]
Arfolitixorin + TEM DC7FGX9 TEM Adenocarcinoma (Cell Line: SW-620) [4]
Arfolitixorin + TEM DCS7SA7 TEM Large cell lung carcinoma (Cell Line: NCI-H460) [4]
Arfolitixorin + TEM DCLUYI5 TEM Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [4]
Arfolitixorin + TEM DCZSVYG TEM Prostate carcinoma (Cell Line: PC-3) [4]
Arfolitixorin + Imatinib DC6CIXM Imatinib Adenocarcinoma (Cell Line: HCT116) [4]
Arfolitixorin + Bleomycin DC0PW1H Bleomycin Adenocarcinoma (Cell Line: SW-620) [4]
Arfolitixorin + Bleomycin DCEJI56 Bleomycin Melanoma (Cell Line: SK-MEL-2) [4]
Arfolitixorin + Bortezomib DCDV9LV Bortezomib Adenocarcinoma (Cell Line: A549) [4]
Arfolitixorin + Cisplatin DC894W7 Cisplatin Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [4]
Arfolitixorin + Sorafenib DCMR4BG Sorafenib Adenocarcinoma (Cell Line: DU-145) [4]
Arfolitixorin + ER819762 DCILTIC ER819762 High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [4]
Arfolitixorin + ER819762 DCOKBT5 ER819762 Melanoma (Cell Line: UACC-257) [4]
Arfolitixorin + Romidepsin DC7AXSR Romidepsin Adenocarcinoma (Cell Line: A549) [4]
Arfolitixorin + Romidepsin DCFT49Y Romidepsin Lung adenocarcinoma (Cell Line: EKVX) [4]
Arfolitixorin + Romidepsin DC4Q928 Romidepsin Lung adenocarcinoma (Cell Line: MDA-MB-231) [4]
Arfolitixorin + Romidepsin DC62PTK Romidepsin Lung adenocarcinoma (Cell Line: NCI-H522) [4]
Arfolitixorin + Romidepsin DCBYT0Q Romidepsin Malignant melanoma (Cell Line: LOX IMVI) [4]
Arfolitixorin + Romidepsin DC8WV6U Romidepsin Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [4]
Arfolitixorin + Romidepsin DCMOULR Romidepsin Prostate carcinoma (Cell Line: PC-3) [4]
Arfolitixorin + Pomalidomide DC4QYTR Pomalidomide Adenocarcinoma (Cell Line: HCT116) [4]
Arfolitixorin + Pomalidomide DCL9328 Pomalidomide Malignant melanoma (Cell Line: UACC62) [4]
Arfolitixorin + Pomalidomide DC9Y6TL Pomalidomide Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [4]
Arfolitixorin + Mercaptopurine DC3ZZEY Mercaptopurine Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [4]
Arfolitixorin + Mepacrine DCRQUQN Mepacrine Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [4]
Arfolitixorin + Fludarabine DC0OI8E Fludarabine Large cell lung carcinoma (Cell Line: NCI-H460) [4]
Arfolitixorin + PMID28870136-Compound-43 DCE6T05 PMID28870136-Compound-43 Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [4]
Arfolitixorin + Aminolevulinic Acid Hydrochloride DCLPFO0 Aminolevulinic Acid Hydrochloride Adenocarcinoma (Cell Line: HT29) [4]
Arfolitixorin + Aminolevulinic Acid Hydrochloride DCBRZMT Aminolevulinic Acid Hydrochloride Melanoma (Cell Line: SK-MEL-2) [4]
Arfolitixorin + Digitoxin DC9JCO0 Digitoxin Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [4]
Arfolitixorin + Busulfan DCRBXKR Busulfan Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [4]
Arfolitixorin + Dasatinib DC7JD92 Dasatinib Adenocarcinoma (Cell Line: SW-620) [4]
Arfolitixorin + Dasatinib DC829YZ Dasatinib Lung adenocarcinoma (Cell Line: NCI-H522) [4]
Arfolitixorin + Dasatinib DC1EV9V Dasatinib Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [4]
Atenolol + Arfolitixorin DCX7AB7 Atenolol Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Azatadine + Arfolitixorin DC4IL27 Azatadine Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
BIO-300 + Arfolitixorin DCMPTLK BIO-300 Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
BIO-300 + Arfolitixorin DCO6IUI BIO-300 Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
BIO-300 + Arfolitixorin DCALE5O BIO-300 Anaplastic large cell lymphoma (Cell Line: SR) [2]
BIO-300 + Arfolitixorin DCMHNI8 BIO-300 Glioma (Cell Line: SF-268) [2]
BIO-300 + Arfolitixorin DC1NA56 BIO-300 Papillary renal cell carcinoma (Cell Line: ACHN) [2]
BIO-300 + Arfolitixorin DC1L7KJ BIO-300 Colon adenocarcinoma (Cell Line: COLO 205) [3]
Bleomycin + Arfolitixorin DC7YS0O Bleomycin Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
Bleomycin + Arfolitixorin DCAN9SJ Bleomycin Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Bleomycin + Arfolitixorin DCRD4G6 Bleomycin Anaplastic large cell lymphoma (Cell Line: SR) [2]
Bleomycin + Arfolitixorin DCCLTVG Bleomycin Astrocytoma (Cell Line: SNB-19) [2]
Bleomycin + Arfolitixorin DCG72C9 Bleomycin Chronic myelogenous leukemia (Cell Line: K-562) [2]
Bleomycin + Arfolitixorin DCE39G3 Bleomycin Clear cell renal cell carcinoma (Cell Line: TK-10) [2]
Bleomycin + Arfolitixorin DCODVVG Bleomycin Glioblastoma (Cell Line: SNB-75) [2]
Bleomycin + Arfolitixorin DC1JN3F Bleomycin Glioma (Cell Line: SF-268) [2]
Bleomycin + Arfolitixorin DCDS4JL Bleomycin Papillary renal cell carcinoma (Cell Line: ACHN) [2]
Bleomycin + Arfolitixorin DC28901 Bleomycin Breast adenocarcinoma (Cell Line: MDA-MB-468) [3]
Bleomycin + Arfolitixorin DCUGIYY Bleomycin Colon adenocarcinoma (Cell Line: COLO 205) [3]
Bleomycin + Arfolitixorin DCTO0WP Bleomycin Colon carcinoma (Cell Line: KM12) [3]
Bleomycin + Arfolitixorin DCCSDFP Bleomycin Invasive ductal carcinoma (Cell Line: HS 578T) [3]
Bleomycin + Arfolitixorin DCYQGGX Bleomycin Invasive ductal carcinoma (Cell Line: T-47D) [3]
Bleomycin + Arfolitixorin DCNJCU6 Bleomycin Adenocarcinoma (Cell Line: OVCAR3) [4]
Bleomycin + Arfolitixorin DCI1SMN Bleomycin Cutaneous melanoma (Cell Line: SK-MEL-5) [4]
Bleomycin + Arfolitixorin DC1FW9U Bleomycin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [4]
Bleomycin + Arfolitixorin DCT2Y42 Bleomycin Large cell lung carcinoma (Cell Line: NCI-H460) [4]
Bleomycin + Arfolitixorin DC0UOB8 Bleomycin Malignant melanoma (Cell Line: LOX IMVI) [4]
Bleomycin + Arfolitixorin DC1S50O Bleomycin Melanoma (Cell Line: SK-MEL-2) [4]
Bleomycin + Arfolitixorin DCBEAE0 Bleomycin Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [4]
Bortezomib + Arfolitixorin DC886XR Bortezomib Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Bosentan + Arfolitixorin DCFDOE7 Bosentan Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
BRL-15572 + Arfolitixorin DCD5ZXX BRL-15572 Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Cabazitaxel + Arfolitixorin DC7QMIR Cabazitaxel Adenocarcinoma (Cell Line: DU-145) [2]
Cabazitaxel + Arfolitixorin DCKV0ZY Cabazitaxel Adenocarcinoma (Cell Line: A549) [2]
Cabazitaxel + Arfolitixorin DCT7VGF Cabazitaxel Adenocarcinoma (Cell Line: HT29) [2]
Cabazitaxel + Arfolitixorin DCUI8FE Cabazitaxel Adenocarcinoma (Cell Line: HCT116) [2]
Cabazitaxel + Arfolitixorin DCH1I66 Cabazitaxel Adenocarcinoma (Cell Line: HCT-15) [2]
Cabazitaxel + Arfolitixorin DCTDRW1 Cabazitaxel Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
Cabazitaxel + Arfolitixorin DCPTLUM Cabazitaxel Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Cabazitaxel + Arfolitixorin DC4XSF9 Cabazitaxel Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [2]
Cabazitaxel + Arfolitixorin DC249F9 Cabazitaxel Glioblastoma (Cell Line: SNB-75) [2]
Cabazitaxel + Arfolitixorin DCO9BB9 Cabazitaxel High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [2]
Cabazitaxel + Arfolitixorin DCJHVPQ Cabazitaxel Large cell lung carcinoma (Cell Line: NCI-H460) [2]
Cabazitaxel + Arfolitixorin DC8T5SS Cabazitaxel Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [2]
Cabazitaxel + Arfolitixorin DCB25EK Cabazitaxel Papillary renal cell carcinoma (Cell Line: ACHN) [2]
Cabazitaxel + Arfolitixorin DCW59RR Cabazitaxel Prostate carcinoma (Cell Line: PC-3) [2]
Cabazitaxel + Arfolitixorin DCR574I Cabazitaxel Renal cell carcinoma (Cell Line: SN12C) [2]
Cabazitaxel + Arfolitixorin DC573RM Cabazitaxel Carcinoma (Cell Line: RXF 393) [3]
Cefmenoxime + Arfolitixorin DCPNR5P Cefmenoxime Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Chlormezanone + Arfolitixorin DCJ4N3F Chlormezanone Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Cilastatin + Arfolitixorin DC0Y50U Cilastatin Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Cisatracurium + Arfolitixorin DC24LYA Cisatracurium Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Citalopram + Arfolitixorin DCWY12V Citalopram Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Clopidogrel + Arfolitixorin DCQR5V1 Clopidogrel Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Crizotinib + Arfolitixorin DCCEAUR Crizotinib Adenocarcinoma (Cell Line: DU-145) [2]
Crizotinib + Arfolitixorin DCHACOS Crizotinib Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Crizotinib + Arfolitixorin DCCLCMJ Crizotinib Astrocytoma (Cell Line: U251) [2]
Crizotinib + Arfolitixorin DCC5QYX Crizotinib Clear cell renal cell carcinoma (Cell Line: CAKI-1) [2]
Crizotinib + Arfolitixorin DCAR13R Crizotinib High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [2]
Crizotinib + Arfolitixorin DCJY36M Crizotinib Large cell lung carcinoma (Cell Line: NCI-H460) [2]
Crizotinib + Arfolitixorin DCQWANF Crizotinib Plasma cell myeloma (Cell Line: RPMI-8226) [2]
Crizotinib + Arfolitixorin DC15G1G Crizotinib Renal cell carcinoma (Cell Line: SN12C) [2]
Crizotinib + Arfolitixorin DCX3G02 Crizotinib Breast adenocarcinoma (Cell Line: MDA-MB-468) [3]
Cytarabine + Arfolitixorin DCB80J6 Cytarabine Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Dacarbazine + Arfolitixorin DC3J0XM Dacarbazine Adenocarcinoma (Cell Line: OVCAR3) [2]
Dacarbazine + Arfolitixorin DCKYLQ0 Dacarbazine Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
Dacarbazine + Arfolitixorin DCZHM7A Dacarbazine Anaplastic large cell lymphoma (Cell Line: SR) [2]
Dacarbazine + Arfolitixorin DC17DYA Dacarbazine Chronic myelogenous leukemia (Cell Line: K-562) [2]
Dacarbazine + Arfolitixorin DCPNPFJ Dacarbazine Glioma (Cell Line: SF-268) [2]
Dacarbazine + Arfolitixorin DC6GHFW Dacarbazine High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [2]
Dacarbazine + Arfolitixorin DC9GYOL Dacarbazine Malignant melanoma (Cell Line: LOX IMVI) [2]
Dacarbazine + Arfolitixorin DCCDQ6S Dacarbazine Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [2]
Dacarbazine + Arfolitixorin DCNQTC3 Dacarbazine Carcinoma (Cell Line: RXF 393) [3]
Dacarbazine + Arfolitixorin DCGBQZN Dacarbazine Colon adenocarcinoma (Cell Line: COLO 205) [3]
Dacarbazine + Arfolitixorin DCEW8IL Dacarbazine Invasive ductal carcinoma (Cell Line: T-47D) [3]
Daidzin + Arfolitixorin DC6ES9O Daidzin Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Dantrolene + Arfolitixorin DCCHYUL Dantrolene Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Desoxycorticosterone pivalate + Arfolitixorin DCBUFA4 Desoxycorticosterone pivalate Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Dexrazoxane + Arfolitixorin DCRP2NI Dexrazoxane Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
Dexrazoxane + Arfolitixorin DCZ3ARH Dexrazoxane Anaplastic large cell lymphoma (Cell Line: SR) [2]
Dexrazoxane + Arfolitixorin DCW8MHS Dexrazoxane Renal cell carcinoma (Cell Line: SN12C) [2]
Dexrazoxane + Arfolitixorin DCRTHFJ Dexrazoxane Breast adenocarcinoma (Cell Line: MDA-MB-468) [3]
Dexrazoxane + Arfolitixorin DCB5S85 Dexrazoxane Carcinoma (Cell Line: RXF 393) [3]
Dexrazoxane + Arfolitixorin DC10U80 Dexrazoxane Colon adenocarcinoma (Cell Line: COLO 205) [3]
Dexrazoxane + Arfolitixorin DCGDL6W Dexrazoxane Invasive ductal carcinoma (Cell Line: HS 578T) [3]
Dexrazoxane + Arfolitixorin DCLY15B Dexrazoxane High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [4]
Dexrazoxane + Arfolitixorin DCGH78C Dexrazoxane Large cell lung carcinoma (Cell Line: NCI-H460) [4]
Dexrazoxane + Arfolitixorin DCP3DNS Dexrazoxane Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [4]
Dihydroergotamine + Arfolitixorin DCX7AHO Dihydroergotamine Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Epirubicin + Arfolitixorin DC5A2LG Epirubicin Chronic myelogenous leukemia (Cell Line: K-562) [2]
Epirubicin + Arfolitixorin DCOY9NK Epirubicin Clear cell renal cell carcinoma (Cell Line: 786-0) [2]
Epirubicin + Arfolitixorin DCD41R1 Epirubicin Clear cell renal cell carcinoma (Cell Line: CAKI-1) [2]
Epirubicin + Arfolitixorin DCL4CJO Epirubicin Papillary renal cell carcinoma (Cell Line: ACHN) [2]
Epirubicin + Arfolitixorin DCWPZCF Epirubicin Renal cell carcinoma (Cell Line: SN12C) [2]
Epirubicin + Arfolitixorin DCTDVGI Epirubicin Renal cell carcinoma (Cell Line: UO-31) [2]
Epirubicin + Arfolitixorin DCQR7YQ Epirubicin Breast adenocarcinoma (Cell Line: MDA-MB-468) [3]
Epirubicin + Arfolitixorin DC7DECE Epirubicin Carcinoma (Cell Line: RXF 393) [3]
Epirubicin + Arfolitixorin DCO1KGX Epirubicin Invasive ductal carcinoma (Cell Line: HS 578T) [3]
Epirubicin + Arfolitixorin DC6E73P Epirubicin Adenocarcinoma (Cell Line: DU-145) [4]
Epirubicin + Arfolitixorin DCRF6HT Epirubicin Lung adenocarcinoma (Cell Line: HOP-62) [4]
Epirubicin + Arfolitixorin DC0JGWX Epirubicin Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [4]
Estramustine + Arfolitixorin DCTZKX6 Estramustine Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Fomepizole + Arfolitixorin DCKLXVY Fomepizole Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Gefitinib + Arfolitixorin DCB4R3K Gefitinib Adenocarcinoma (Cell Line: OVCAR3) [2]
Gefitinib + Arfolitixorin DCWX9V1 Gefitinib Chronic myelogenous leukemia (Cell Line: K-562) [2]
Gefitinib + Arfolitixorin DC7ZH06 Gefitinib Glioma (Cell Line: SF-268) [2]
Gefitinib + Arfolitixorin DCH72KU Gefitinib Melanoma (Cell Line: SK-MEL-2) [2]
Gefitinib + Arfolitixorin DCUHP9A Gefitinib Melanoma (Cell Line: UACC-257) [2]
Gefitinib + Arfolitixorin DCQ7HFW Gefitinib Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [2]
Gefitinib + Arfolitixorin DCADS4J Gefitinib Papillary renal cell carcinoma (Cell Line: ACHN) [2]
Gefitinib + Arfolitixorin DC0UHDB Gefitinib Prostate carcinoma (Cell Line: PC-3) [2]
Gefitinib + Arfolitixorin DCRF195 Gefitinib Breast adenocarcinoma (Cell Line: MDA-MB-468) [3]
Gefitinib + Arfolitixorin DC6ABJR Gefitinib Carcinoma (Cell Line: RXF 393) [3]
GINKGOLIDE A + Arfolitixorin DCUHT57 GINKGOLIDE A Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Ibutilide + Arfolitixorin DC5RY02 Ibutilide Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Imatinib + Arfolitixorin DCMGJ0H Imatinib Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Imipramine + Arfolitixorin DC2H6WG Imipramine Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Indazole derivative 5 + Arfolitixorin DCQZN8Y Indazole derivative 5 Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Indazole derivative 5 + Arfolitixorin DC4TXOY Indazole derivative 5 Astrocytoma (Cell Line: SNB-19) [2]
Indazole derivative 5 + Arfolitixorin DC6ATLE Indazole derivative 5 Clear cell renal cell carcinoma (Cell Line: 786-0) [2]
Indazole derivative 5 + Arfolitixorin DCA4SHD Indazole derivative 5 Glioblastoma (Cell Line: SNB-75) [2]
Indazole derivative 5 + Arfolitixorin DCNN8TM Indazole derivative 5 Renal cell carcinoma (Cell Line: SN12C) [2]
Indazole derivative 5 + Arfolitixorin DCUDBPP Indazole derivative 5 Breast adenocarcinoma (Cell Line: MDA-MB-468) [3]
Indazole derivative 5 + Arfolitixorin DCBPQE0 Indazole derivative 5 Carcinoma (Cell Line: RXF 393) [3]
Indazole derivative 5 + Arfolitixorin DCYLNE3 Indazole derivative 5 Carcinoma (Cell Line: MCF7) [3]
Indazole derivative 5 + Arfolitixorin DCLFUE5 Indazole derivative 5 Adenocarcinoma (Cell Line: DU-145) [4]
Indazole derivative 5 + Arfolitixorin DCSP1YC Indazole derivative 5 High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [4]
Indazole derivative 5 + Arfolitixorin DCT9LBC Indazole derivative 5 High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [4]
Isoproterenol + Arfolitixorin DCG0IAX Isoproterenol Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Isosorbide dinitrate + Arfolitixorin DCI7UT4 Isosorbide dinitrate Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Lefaxin + Arfolitixorin DCRE1JV Lefaxin Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Lenalidomide + Arfolitixorin DCN4HFP Lenalidomide Carcinoma (Cell Line: RXF 393) [3]
Lenalidomide + Arfolitixorin DC6XVG0 Lenalidomide Adenocarcinoma (Cell Line: HT29) [4]
Lenalidomide + Arfolitixorin DCW548A Lenalidomide Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [4]
Levamisole + Arfolitixorin DCRJTUS Levamisole Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Linagliptin + Arfolitixorin DCVNESL Linagliptin Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Mebutamate + Arfolitixorin DC6SHSO Mebutamate Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Mechlorethamine + Arfolitixorin DCBD9F9 Mechlorethamine Carcinoma (Cell Line: RXF 393) [3]
Mechlorethamine + Arfolitixorin DCCFOO5 Mechlorethamine Colon adenocarcinoma (Cell Line: COLO 205) [3]
Mechlorethamine + Arfolitixorin DCK6CEH Mechlorethamine Invasive ductal carcinoma (Cell Line: HS 578T) [3]
Mechlorethamine + Arfolitixorin DC7V0TO Mechlorethamine Adenocarcinoma (Cell Line: OVCAR3) [4]
Mechlorethamine + Arfolitixorin DC6LLQI Mechlorethamine High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [4]
Mechlorethamine + Arfolitixorin DCTYLQI Mechlorethamine Melanoma (Cell Line: SK-MEL-2) [4]
Mechlorethamine + Arfolitixorin DCCSD19 Mechlorethamine Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [4]
Mechlorethamine + Arfolitixorin DCEEKGA Mechlorethamine Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [4]
Metaxalone + Arfolitixorin DC6RIWL Metaxalone Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Metformin + Arfolitixorin DCZ7C5H Metformin Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Mycophenolic acid + Arfolitixorin DCMMG4G Mycophenolic acid Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Naltrexone + Arfolitixorin DCXID4B Naltrexone Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Niclosamide + Arfolitixorin DC9Q9LU Niclosamide Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Nitisinone + Arfolitixorin DC4BW2K Nitisinone Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Nizatidine + Arfolitixorin DCZ3C0K Nizatidine Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Olanzapine + Arfolitixorin DCC89TF Olanzapine Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Oseltamivir + Arfolitixorin DCSTO6E Oseltamivir Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Oxyphenbutazone + Arfolitixorin DC3NU2Q Oxyphenbutazone Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Paromomycin + Arfolitixorin DCWRYPU Paromomycin Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Pentamidine + Arfolitixorin DCJVZQC Pentamidine Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
PF-02545920 + Arfolitixorin DCJ3FGP PF-02545920 Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Picoplatin + Arfolitixorin DC6SABW Picoplatin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [4]
Picoplatin + Arfolitixorin DC4KZR8 Picoplatin Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [4]
PMID28870136-Compound-43 + Arfolitixorin DCIWNJ3 PMID28870136-Compound-43 Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Raloxifene + Arfolitixorin DC9HMBY Raloxifene Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
Raloxifene + Arfolitixorin DCDS7E0 Raloxifene Anaplastic large cell lymphoma (Cell Line: SR) [2]
Raloxifene + Arfolitixorin DCE9FO4 Raloxifene Astrocytoma (Cell Line: U251) [2]
Raloxifene + Arfolitixorin DCW8948 Raloxifene Chronic myelogenous leukemia (Cell Line: K-562) [2]
Raloxifene + Arfolitixorin DC106LX Raloxifene Glioma (Cell Line: SF-268) [2]
Raloxifene + Arfolitixorin DCDKTSR Raloxifene Glioma (Cell Line: SF-539) [2]
Raloxifene + Arfolitixorin DCCDVTU Raloxifene Glioma (Cell Line: SF-295) [2]
Raloxifene + Arfolitixorin DC1LYHF Raloxifene Carcinoma (Cell Line: RXF 393) [3]
Raloxifene + Arfolitixorin DCQF9W8 Raloxifene Colon adenocarcinoma (Cell Line: COLO 205) [3]
Raloxifene + Arfolitixorin DCDB265 Raloxifene Adenocarcinoma (Cell Line: DU-145) [4]
Raloxifene + Arfolitixorin DCW0XVO Raloxifene Adenocarcinoma (Cell Line: OVCAR3) [4]
Raloxifene + Arfolitixorin DCZUZOO Raloxifene Adenocarcinoma (Cell Line: HCT116) [4]
Raloxifene + Arfolitixorin DCN4VHF Raloxifene Adenocarcinoma (Cell Line: SW-620) [4]
Raloxifene + Arfolitixorin DCCH5NV Raloxifene High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [4]
Raloxifene + Arfolitixorin DCGXLDC Raloxifene Non-small cell lung carcinoma (Cell Line: HOP-92) [4]
Raloxifene + Arfolitixorin DCZXX2S Raloxifene Prostate carcinoma (Cell Line: PC-3) [4]
Rifampin + Arfolitixorin DCAKS5V Rifampin Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Ruxolitinib + Arfolitixorin DCYIAYN Ruxolitinib Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Ruxolitinib + Arfolitixorin DCDC6RB Ruxolitinib Clear cell renal cell carcinoma (Cell Line: 786-0) [2]
Ruxolitinib + Arfolitixorin DCV6K4T Ruxolitinib Renal cell carcinoma (Cell Line: SN12C) [2]
Ruxolitinib + Arfolitixorin DCN7QXA Ruxolitinib Breast adenocarcinoma (Cell Line: MDA-MB-468) [3]
Ruxolitinib + Arfolitixorin DC8J0WW Ruxolitinib Carcinoma (Cell Line: RXF 393) [3]
Ruxolitinib + Arfolitixorin DCMA4JH Ruxolitinib Adenocarcinoma (Cell Line: DU-145) [4]
Ruxolitinib + Arfolitixorin DCLDE8M Ruxolitinib High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [4]
Sertraline + Arfolitixorin DC9N6GU Sertraline Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Sivelestat + Arfolitixorin DCQMBPP Sivelestat Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Tamoxifen + Arfolitixorin DC5U75R Tamoxifen Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Terameprocol + Arfolitixorin DCUT50K Terameprocol Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Thioguanine + Arfolitixorin DC6YOB8 Thioguanine Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
Thioguanine + Arfolitixorin DCO4YXO Thioguanine Anaplastic large cell lymphoma (Cell Line: SR) [2]
Thioguanine + Arfolitixorin DCXXSQ6 Thioguanine Astrocytoma (Cell Line: U251) [2]
Thioguanine + Arfolitixorin DCSJCQR Thioguanine Astrocytoma (Cell Line: SNB-19) [2]
Thioguanine + Arfolitixorin DC19546 Thioguanine Clear cell renal cell carcinoma (Cell Line: 786-0) [2]
Thioguanine + Arfolitixorin DCWHAAT Thioguanine Clear cell renal cell carcinoma (Cell Line: CAKI-1) [2]
Thioguanine + Arfolitixorin DCIGQ3S Thioguanine Glioma (Cell Line: SF-268) [2]
Thioguanine + Arfolitixorin DCC366W Thioguanine Papillary renal cell carcinoma (Cell Line: ACHN) [2]
Thioguanine + Arfolitixorin DCN7H2H Thioguanine Renal cell carcinoma (Cell Line: SN12C) [2]
Thioguanine + Arfolitixorin DCNJXQF Thioguanine Breast adenocarcinoma (Cell Line: MDA-MB-468) [3]
Thioguanine + Arfolitixorin DCMUFZB Thioguanine Carcinoma (Cell Line: RXF 393) [3]
Thioguanine + Arfolitixorin DCCTD05 Thioguanine Colon adenocarcinoma (Cell Line: COLO 205) [3]
Thioguanine + Arfolitixorin DCXO112 Thioguanine Adenocarcinoma (Cell Line: OVCAR3) [4]
Thioguanine + Arfolitixorin DC5SKCB Thioguanine Large cell lung carcinoma (Cell Line: NCI-H460) [4]
Thioguanine + Arfolitixorin DCTER85 Thioguanine Malignant melanoma (Cell Line: LOX IMVI) [4]
Thioguanine + Arfolitixorin DCKJT66 Thioguanine Melanoma (Cell Line: SK-MEL-2) [4]
Thioguanine + Arfolitixorin DCX3ZIT Thioguanine Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [4]
Tolvaptan + Arfolitixorin DC6O8YL Tolvaptan Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Topotecan + Arfolitixorin DC8GNGX Topotecan Carcinoma (Cell Line: RXF 393) [3]
Topotecan + Arfolitixorin DC1X243 Topotecan Invasive ductal carcinoma (Cell Line: HS 578T) [3]
Topotecan + Arfolitixorin DCRCYKT Topotecan Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [4]
Topotecan + Arfolitixorin DC2I09O Topotecan Clear cell renal cell carcinoma (Cell Line: CAKI-1) [4]
Topotecan + Arfolitixorin DCZDKN5 Topotecan Glioma (Cell Line: SF-268) [4]
Topotecan + Arfolitixorin DCP1NN9 Topotecan High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [4]
Topotecan + Arfolitixorin DCNCJ2N Topotecan Lung adenocarcinoma (Cell Line: EKVX) [4]
Topotecan + Arfolitixorin DC8I9Z3 Topotecan Melanoma (Cell Line: UACC-257) [4]
Topotecan + Arfolitixorin DCTV704 Topotecan Melanoma (Cell Line: MALME-3M) [4]
Topotecan + Arfolitixorin DCFY4BF Topotecan Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [4]
Topotecan + Arfolitixorin DCEKHT3 Topotecan Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [4]
Topotecan + Arfolitixorin DCINZO1 Topotecan Papillary renal cell carcinoma (Cell Line: ACHN) [4]
Topotecan + Arfolitixorin DCLFTRL Topotecan Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [4]
Trazodone + Arfolitixorin DC4Y591 Trazodone Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Trifluridine + Arfolitixorin DCI7Y1Y Trifluridine Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
Trifluridine + Arfolitixorin DC65JCJ Trifluridine Breast adenocarcinoma (Cell Line: MDA-MB-468) [3]
Trifluridine + Arfolitixorin DCWEY7M Trifluridine Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [4]
Triiodothyronine + Arfolitixorin DCXRTSM Triiodothyronine Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Trimethobenzamide + Arfolitixorin DCGAYTE Trimethobenzamide Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Uracil mustard + Arfolitixorin DC74Y0Y Uracil mustard Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
Uracil mustard + Arfolitixorin DCRNPF2 Uracil mustard Anaplastic large cell lymphoma (Cell Line: SR) [2]
Uracil mustard + Arfolitixorin DCS4HAJ Uracil mustard Chronic myelogenous leukemia (Cell Line: K-562) [2]
Uracil mustard + Arfolitixorin DCUMO9B Uracil mustard Glioma (Cell Line: SF-295) [2]
Uracil mustard + Arfolitixorin DCAQSPC Uracil mustard Papillary renal cell carcinoma (Cell Line: ACHN) [2]
Uracil mustard + Arfolitixorin DC4C1XF Uracil mustard Malignant melanoma (Cell Line: LOX IMVI) [4]
Uracil mustard + Arfolitixorin DCRVOWM Uracil mustard Melanoma (Cell Line: SK-MEL-2) [4]
Valproic Acid + Arfolitixorin DC4WE4C Valproic Acid Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Vandetanib + Arfolitixorin DCWMXHC Vandetanib Breast adenocarcinoma (Cell Line: MDA-MB-468) [3]
Vandetanib + Arfolitixorin DC73R4L Vandetanib Carcinoma (Cell Line: RXF 393) [3]
Vandetanib + Arfolitixorin DCRSWT7 Vandetanib Invasive ductal carcinoma (Cell Line: HS 578T) [3]
Vandetanib + Arfolitixorin DCGOR6M Vandetanib Adenocarcinoma (Cell Line: DU-145) [4]
Vandetanib + Arfolitixorin DC3HX3D Vandetanib Adenocarcinoma (Cell Line: A549) [4]
Vandetanib + Arfolitixorin DC7ZY9E Vandetanib Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [4]
Vandetanib + Arfolitixorin DCWB51A Vandetanib Astrocytoma (Cell Line: U251) [4]
Vandetanib + Arfolitixorin DCAMKT8 Vandetanib Astrocytoma (Cell Line: SNB-19) [4]
Vandetanib + Arfolitixorin DC8OHG3 Vandetanib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [4]
Vandetanib + Arfolitixorin DC1T2M6 Vandetanib Plasma cell myeloma (Cell Line: RPMI-8226) [4]
Vandetanib + Arfolitixorin DC73HKI Vandetanib Renal cell carcinoma (Cell Line: SN12C) [4]
Vemurafenib + Arfolitixorin DCSRMP7 Vemurafenib Breast adenocarcinoma (Cell Line: MDA-MB-468) [3]
Vemurafenib + Arfolitixorin DCMUG3U Vemurafenib Carcinoma (Cell Line: RXF 393) [3]
Vemurafenib + Arfolitixorin DC14OG4 Vemurafenib Colon adenocarcinoma (Cell Line: COLO 205) [3]
Vemurafenib + Arfolitixorin DCKTQTB Vemurafenib Invasive ductal carcinoma (Cell Line: HS 578T) [3]
Vemurafenib + Arfolitixorin DC2HB7K Vemurafenib Adenocarcinoma (Cell Line: DU-145) [4]
Vemurafenib + Arfolitixorin DCLA43W Vemurafenib Astrocytoma (Cell Line: U251) [4]
Vemurafenib + Arfolitixorin DCDGYDO Vemurafenib Chronic myelogenous leukemia (Cell Line: K-562) [4]
Vemurafenib + Arfolitixorin DCMENQZ Vemurafenib Clear cell renal cell carcinoma (Cell Line: 786-0) [4]
Vemurafenib + Arfolitixorin DCR81DC Vemurafenib Clear cell renal cell carcinoma (Cell Line: CAKI-1) [4]
Vemurafenib + Arfolitixorin DCW18LO Vemurafenib High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [4]
Vemurafenib + Arfolitixorin DCOVCSJ Vemurafenib Malignant melanoma (Cell Line: LOX IMVI) [4]
Vemurafenib + Arfolitixorin DCMP9CA Vemurafenib Plasma cell myeloma (Cell Line: RPMI-8226) [4]
Vemurafenib + Arfolitixorin DC1S73L Vemurafenib Renal cell carcinoma (Cell Line: SN12C) [4]
Vismodegib + Arfolitixorin DCVMC7M Vismodegib Breast adenocarcinoma (Cell Line: MDA-MB-468) [3]
Vismodegib + Arfolitixorin DCTFV7O Vismodegib Adenocarcinoma (Cell Line: DU-145) [4]
Vismodegib + Arfolitixorin DC207ZS Vismodegib Renal cell carcinoma (Cell Line: SN12C) [4]
------------------------------------------------------------------------------------
⏷ Show the Full List of 595 DrugCom(s)
2 Clinical Trial Drug Combination(s) Consisting of This drug
DrugCom Name DrugCom ID Component Drug Indication REF
Arfolitixorin + Pemetrexed DC9VZIB Pemetrexed Rectal Cancer [5]
Arfolitixorin + Leucovorin DCHX15Z Leucovorin Osteosarcoma [6]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT03750786) A Study to Compare the Efficacy of Arfolitixorin Versus Leucovorin in Combination With 5 Fluorouracil, Oxaliplatin, and Bevacizumab in Patients With Advanced Colorectal Cancer (AGENT). U.S. National Institutes of Health.
2 Recurrent recessive mutation in deoxyguanosine kinase causes idiopathic noncirrhotic portal hypertension.Hepatology. 2016 Jun;63(6):1977-86. doi: 10.1002/hep.28499. Epub 2016 Mar 31.
3 Biologically active neutrophil chemokine pattern in tonsillitis.Clin Exp Immunol. 2004 Mar;135(3):511-8. doi: 10.1111/j.1365-2249.2003.02390.x.
4 Loss of function mutations in VARS encoding cytoplasmic valyl-tRNA synthetase cause microcephaly, seizures, and progressive cerebral atrophy.Hum Genet. 2018 Apr;137(4):293-303. doi: 10.1007/s00439-018-1882-3. Epub 2018 Apr 24.
5 ClinicalTrials.gov (NCT01397305) An Extended Feasibility Phase I/II Study of Methylenetetrahydrofolate (Arfolitixorin) and Pemetrexed Single Agent, Given as Neoadjuvant Treatment in Patients With Resectable Rectal Cancer
6 ClinicalTrials.gov (NCT01987102) Investigation of [6R] 5,10-methylenetetrahydrofolate (Arfolitixorin) as Rescue Therapy for Osteosarcoma Patients Treated With HDMTX.